New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

PT-141 (Bremelanotide)

From $65.00

Shop

PT-141 (Bremelanotide) · Research brief

Buy Bremelanotide — Research-Grade PT-141 | Real Peptides

52 WORDS

Short answer

Bremelanotide (PT-141) sales increased 340% between 2022 and 2025 across research institutions studying melanocortin receptor pathways, yet fewer than 15% of suppliers can verify batch-level purity testing through independent third-party laboratories. Most peptide degradation happens before the vial ever reaches your lab. During synthesis, lyophilization, or storage. Not during your experimental protocol.

Key takeaways

  • Bremelanotide (PT-141) acts as a melanocortin receptor agonist targeting MC3R and MC4R pathways, with a cyclic heptapeptide structure that provides a 2.7-hour plasma half-life resistant to enzymatic degradation.
  • Research-grade bremelanotide requires ≥98% HPLC purity plus mass spectrometry confirmation of 1025.2 g/mol molecular weight to ensure accurate receptor binding studies.
  • Peptide content by mass should exceed 80%. A vial might be '98% pure' but contain only 70% actual peptide if counterions and residual water aren't accounted for.
  • Temperature excursions above 25°C during shipping or storage cause tryptophan oxidation and lactam bridge hydrolysis, converting functional cyclic peptide to inactive linear forms.
  • Real Peptides provides batch-specific HPLC chromatograms, MALDI-TOF mass spectra, and residual TFA analysis (<50 ppm) with temperature-monitored cold chain shipping to preserve molecular integrity.
  • MC4R activation in hypothalamic and limbic structures makes bremelanotide a research tool for studying centrally-mediated behavioral pathways distinct from peripheral mechanisms.

Bremelanotide (PT-141) sales increased 340% between 2022 and 2025 across research institutions studying melanocortin receptor pathways, yet fewer than 15% of suppliers can verify batch-level purity testing through independent third-party laboratories. Most peptide degradation happens before the vial ever reaches your lab. During synthesis, lyophilization, or storage. Not during your experimental protocol.

We've supplied research-grade peptides to hundreds of laboratories conducting melanocortin studies. The gap between ordering functional bremelanotide and receiving degraded powder comes down to three supplier practices most researchers never think to verify.

What does it mean to buy bremelanotide for research purposes?

To buy bremelanotide means acquiring PT-141, a synthetic heptapeptide analog of alpha-melanocyte stimulating hormone (α-MSH), in lyophilized powder form at ≥98% purity for in vitro or animal model research. Bremelanotide acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R pathways studied in neuroscience, behavioral pharmacology, and reproductive biology research. Research-grade bremelanotide from Real Peptides ships with independent HPLC and mass spectrometry verification confirming exact amino acid sequencing and molecular weight of 1025.2 g/mol.

Most researchers assume all bremelanotide powder is functionally identical if the label says 'PT-141'. But peptide synthesis quality varies dramatically by manufacturer. A 95% purity peptide contains 5% impurities that can include deletion sequences, truncated chains, or oxidized residues that interfere with receptor binding in your assays. This article covers exactly how melanocortin receptor agonists like bremelanotide work at the molecular level, what purity specifications matter for reproducible research, and how to verify supplier claims before you buy bremelanotide for your laboratory.

Understanding Bremelanotide's Mechanism and Research Applications

Bremelanotide (PT-141) functions as a cyclic heptapeptide with the sequence Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH, designed to resist enzymatic degradation while maintaining high affinity for melanocortin receptors MC3R and MC4R. Unlike linear peptides that degrade rapidly in biological systems, the cyclic structure created by the lactam bridge between aspartic acid and lysine residues extends the half-life to approximately 2.7 hours in plasma. Making it suitable for acute dosing studies without the confounding variables of rapid clearance.

The melanocortin system regulates multiple physiological processes beyond pigmentation, including energy homeostasis, sexual function, inflammation, and cardiovascular tone. MC4R receptors concentrate densely in hypothalamic nuclei (paraventricular nucleus, arcuate nucleus) and limbic structures (amygdala, nucleus accumbens), positioning bremelanotide as a research tool for studying central nervous system pathways that conventional neurotransmitter-focused compounds don't address. Research published in the Journal of Sexual Medicine demonstrated MC4R activation in the medial preoptic area (MPOA) increased dopamine release and neural activation patterns distinct from peripheral vascular mechanisms. A finding that reshaped understanding of centrally-mediated arousal pathways.

Current research applications include investigating MC4R's role in pair bonding behaviors, stress-induced anhedonia models, and metabolic regulation studies where melanocortin signaling intersects with leptin and insulin pathways. The peptide's ability to cross the blood-brain barrier following subcutaneous administration makes it particularly valuable for behavioral neuroscience protocols that require systemic dosing without intracerebroventricular injection procedures. When you buy bremelanotide for these research contexts, molecular integrity is non-negotiable. A single amino acid substitution or oxidation at the tryptophan residue can reduce MC4R binding affinity by 60–80%.

Our small-batch synthesis process at Real Peptides uses Fmoc solid-phase peptide synthesis (SPPS) with real-time monitoring at each coupling step, followed by cyclization under controlled pH conditions that prevent racemization of the D-phenylalanine residue. Every batch undergoes reverse-phase HPLC analysis confirming the single peak at the expected retention time, plus MALDI-TOF mass spectrometry verifying molecular weight within ±0.5 Da of the theoretical 1025.2 g/mol target. This level of verification isn't standard across suppliers. Many ship peptides with certificate of analysis data from the raw material manufacturer without independent confirmation of the final lyophilized product.

Purity Standards and Quality Verification When You Buy Bremelanotide

Peptide purity exists on a spectrum, and the percentage listed on a product label doesn't tell you what comprises the remaining fraction. A peptide sold as '95% pure' could contain 5% water, 5% residual trifluoroacetic acid (TFA) from synthesis, or 5% deletion sequences missing one or more amino acids. Each scenario has different implications for your experimental results. High-performance liquid chromatography (HPLC) purity measures the percentage of the target peptide peak relative to all UV-absorbing compounds in the sample, but it doesn't distinguish between the correct sequence and a closely-related impurity with similar retention time.

Mass spectrometry adds the critical second dimension by confirming molecular weight. Bremelanotide's theoretical monoisotopic mass is 1025.2 g/mol. If your supplier's mass spec shows peaks at 1011 g/mol or 1039 g/mol alongside the target peak, those represent deletion or addition sequences that will compete for receptor binding or act as partial agonists with different efficacy profiles. For dose-response studies or competitive binding assays, these impurities introduce variability that no amount of statistical power can resolve.

When you buy bremelanotide from Real Peptides, you receive a certificate of analysis showing both analytical methods for every batch. Our HPLC chromatograms display single sharp peaks at ≥98.5% area under curve, and MALDI-TOF spectra confirm the target mass with no significant impurity peaks above 0.5% relative intensity. We also test for residual TFA content. A common synthesis byproduct that increases apparent peptide mass and can cause injection site irritation in animal studies if present above 100 ppm. Our TFA levels consistently measure below 50 ppm through ion chromatography analysis.

The storage and handling chain matters as much as initial synthesis quality. Lyophilized bremelanotide stored at −20°C in sealed vials under inert atmosphere (argon or nitrogen) maintains ≥95% potency for 24 months based on stability studies tracking HPLC purity over time. Exposure to moisture initiates hydrolysis of the peptide backbone, particularly at the lactam bridge that creates the cyclic structure. Once that ring opens, you have a linear heptapeptide with dramatically different pharmacological properties. Temperature excursions above 25°C accelerate oxidation of the tryptophan residue, producing kynurenine derivatives that absorb at different wavelengths and shift your HPLC retention time.

We ship all peptides in insulated containers with temperature data loggers that record the entire transit environment. If your package experiences temperatures above 8°C for more than 4 hours during shipping, that data appears on your tracking portal and we replace the order at no cost. Most suppliers ship peptides in standard bubble mailers with no temperature control. By the time the package reaches a laboratory in a warm climate during summer months, peptide integrity is already compromised.

Buy Bremelanotide: Product Specification Comparison

Before you buy bremelanotide, understanding how supplier specifications translate to experimental reliability helps you avoid the false economy of choosing price over purity. The table below compares key quality markers across typical supplier tiers.

Specification Research-Grade (Real Peptides) Standard Commercial Bulk/Generic
HPLC Purity ≥98.5% (verified per batch) ≥95% (manufacturer claim) ≥90% (no batch verification)
Mass Spec Confirmation MALDI-TOF on every batch, ±0.5 Da ESI-MS on representative samples Often not performed
Amino Acid Sequencing Confirmed via Edman degradation or MS/MS Not routinely verified Not verified
Residual TFA Content <50 ppm (ion chromatography) Not tested or >200 ppm Not tested
Lyophilization Protocol Controlled freeze-drying under inert gas Standard vacuum drying Variable or unknown
Storage During Transit Temperature-monitored cold chain shipping Ambient shipping, no monitoring Ambient shipping
Certificate of Analysis Batch-specific HPLC + MS + TFA data Generic or batch-averaged data Often not provided
Guaranteed Peptide Content ≥80% by mass (remainder = counterion + moisture) ≥70% peptide content Unknown or <70%
Professional Assessment Suitable for publication-grade research requiring reproducibility Acceptable for preliminary screening studies High risk of batch-to-batch variability affecting results

The 'peptide content' row matters more than many researchers realize. A 10mg vial labeled '98% pure' might contain 8mg actual peptide and 2mg acetate counterion plus residual water. That's legitimate. But if peptide content by mass is only 65%, that same vial contains 6.5mg peptide, meaning your 1mM stock solution is actually 0.65mM and every downstream dilution is off by 35%. When you buy bremelanotide, ask suppliers for peptide content data in addition to purity percentage.

What If: Bremelanotide Research Scenarios

What If the Peptide Arrives Warm Due to Shipping Delays?

Refrigerate the vial immediately and request the temperature log from your supplier before using the peptide in experiments. Lyophilized bremelanotide can tolerate brief ambient temperature exposure (24–48 hours at 20–25°C) without significant degradation, but prolonged exposure above 30°C or any time above 40°C likely caused irreversible structural changes. Reconstitute a small test aliquot and run analytical HPLC if you have access. If the chromatogram shows multiple peaks or the main peak retention time shifted by more than 0.2 minutes from the certificate of analysis, the batch is compromised. For critical experiments, don't risk using peptide with unknown thermal history. The cost of repeating failed experiments due to degraded reagent far exceeds the cost of a replacement vial.

What If Reconstituted Bremelanotide Appears Cloudy or Contains Particulates?

Do not use cloudy or particulate-containing peptide solutions in any research protocol. Cloudiness indicates either incomplete dissolution, precipitation due to pH incompatibility, or microbial contamination if the bacteriostatic water was compromised. Bremelanotide should dissolve completely in sterile water, bacteriostatic water, or phosphate-buffered saline at pH 6.5–7.5 to produce a clear, colorless solution. If cloudiness appears immediately after adding solvent, the lyophilized cake may contain high residual salt content. Try adjusting pH to 7.0 with dilute sodium hydroxide. If particulates appear hours after reconstitution during refrigerated storage, microbial growth is the likely cause and the solution must be discarded.

What If You Need to Verify Peptide Identity Before Starting a Long-Term Study?

Request a small analytical sample (1–2mg) before purchasing your full research quantity and run independent HPLC-MS analysis through your institution's core facility or a third-party analytical lab. The cost of confirming peptide identity ($150–300 for HPLC-MS) is negligible compared to months of wasted research time using mislabeled or contaminated material. Compare the observed molecular weight to the theoretical 1025.2 g/mol for bremelanotide. If the mass is off by more than 1 Da, you either have the wrong peptide or significant impurities. We encourage this verification step and provide reference samples at no additional cost when you buy bremelanotide in quantities above 50mg for extended studies.

The Research-Grade Truth About Buying Bremelanotide

Here's the honest answer: the peptide market contains far more low-quality bremelanotide than research-grade material, and price is often the only obvious differentiator. A 10mg vial priced at $45 and a 10mg vial priced at $180 might both claim '98% purity'. The difference is whether that purity claim is verified through independent third-party analysis on the specific batch you receive, or copied from a manufacturer's representative certificate of analysis that may be years old.

The bottom line is this: if your research will be published, presented at conferences, or used to support grant applications or patent filings, using peptides without batch-verified purity data creates risk that outweighs any cost savings. Reviewers increasingly request detailed reagent characterization, and 'we purchased from Supplier X' doesn't satisfy that requirement. When you buy bremelanotide from Real Peptides, you receive documentation sufficient to include in methods sections of peer-reviewed publications. HPLC chromatograms, mass spectra, and peptide content analysis specific to your batch number.

For preliminary screening work or method development, lower-purity commercial-grade peptides may be acceptable if you understand the limitations. But for dose-response studies, receptor binding assays, in vivo behavioral experiments, or any research where reproducibility matters, the molecular integrity of your starting material determines whether your data tells a clear story or generates noise you'll spend months trying to explain.

If you're comparing suppliers based solely on price per milligram, you're optimizing the wrong variable. The real cost includes experiment failures, wasted animal subjects in protocols that used degraded peptide, and the opportunity cost of months spent troubleshooting an assay that would have worked perfectly with properly characterized reagent. We've seen research groups abandon promising hypotheses because their initial experiments with low-quality bremelanotide produced inconsistent results. They concluded the peptide 'doesn't work in our model' when the actual problem was peptide quality, not the biological hypothesis.

Bremelanotide research continues expanding into new applications investigating melanocortin signaling in metabolic disease, addiction neuroscience, and social behavior models. The quality of insights you generate depends entirely on the quality of tools you use. When your experimental timeline spans months and your funding is finite, buying research-grade peptides from the start isn't an optional premium. It's the baseline requirement for generating publication-quality data.

Real Peptides synthesizes every batch in small quantities with exact amino acid sequencing, lyophilizes under controlled conditions, and ships with full analytical documentation because that's what reproducible research requires. Explore our PT-141 Bremelanotide and see how verified purity translates to experimental confidence, or browse our full peptide collection to find additional research tools manufactured to the same standards.

The researchers who consistently generate clean data didn't find a magic protocol. They started with peptides that actually contain what the label claims, at the purity the certificate states, delivered in condition to perform as expected. That's not a luxury standard. That's just research-grade peptide supply done correctly.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Bremelanotide is a synthetic cyclic heptapeptide that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R pathways in the central nervous system. Research applications include behavioral neuroscience studies investigating central arousal pathways, energy homeostasis and metabolic regulation, stress-induced anhedonia models, and pair bonding behaviors. The peptide’s ability to cross the blood-brain barrier following subcutaneous administration makes it valuable for systemic dosing studies without requiring intracerebroventricular injection procedures.
Verify purity by requesting batch-specific certificates of analysis showing both HPLC chromatograms (should show ≥98% purity as a single sharp peak) and mass spectrometry data confirming molecular weight of 1025.2 g/mol within ±0.5 Da. Check for residual TFA content (should be <100 ppm, ideally <50 ppm) and ask for peptide content by mass, which should exceed 80%. For critical research, request a small analytical sample and run independent HPLC-MS through your institution's core facility before purchasing larger quantities.
Store lyophilized bremelanotide at −20°C in sealed vials under inert atmosphere, which maintains ≥95% potency for 24 months. Once reconstituted with bacteriostatic water or sterile saline, store at 2–8°C (refrigerated) and use within 28 days. Avoid temperature excursions above 25°C, which accelerate oxidation of the tryptophan residue and can hydrolyze the lactam bridge that creates the cyclic structure. Never freeze reconstituted peptide solutions, as freeze-thaw cycles cause aggregation and precipitation.
Yes, bremelanotide is commonly used in animal model research due to its ability to cross the blood-brain barrier following subcutaneous or intraperitoneal administration. The plasma half-life is approximately 2.7 hours in rodent models, making it suitable for acute dosing studies. The cyclic structure provides resistance to enzymatic degradation compared to linear peptides, allowing for consistent exposure during behavioral testing windows without the confounding variables of rapid clearance or the need for continuous infusion protocols.
Common impurities include deletion sequences (peptides missing one or more amino acids), truncated chains, oxidized residues (particularly at the tryptophan position), and residual trifluoroacetic acid from synthesis. Deletion sequences can act as partial agonists or competitive antagonists at melanocortin receptors, creating dose-response curves that don’t match theoretical models. Oxidized tryptophan residues reduce MC4R binding affinity by 60–80%, causing apparent ‘low potency’ that’s actually an artifact of degraded reagent. High TFA content (>200 ppm) can cause injection site irritation in animal studies and shift solution pH.
Bremelanotide offers higher selectivity for MC4R over MC1R compared to non-selective agonists like melanotan II, reducing off-target effects on pigmentation pathways in chronic dosing studies. The cyclic structure provides superior proteolytic stability compared to linear α-MSH analogs, extending duration of action without continuous infusion. However, for studies specifically investigating MC3R-selective effects, other research compounds may provide better receptor subtype discrimination. Bremelanotide’s primary advantage is well-characterized pharmacokinetics and extensive published literature supporting melanocortin-mediated behavioral effects.
The D-phenylalanine at position 4 in the sequence provides resistance to enzymatic cleavage by proteases that recognize L-amino acid substrates, significantly extending the peptide’s biological half-life. This stereochemical modification is critical for receptor binding geometry — racemization of the D-phenylalanine back to L-phenylalanine during synthesis or storage produces a diastereomer with dramatically reduced MC4R affinity. Quality synthesis protocols prevent racemization through controlled pH during cyclization, which is why batch-verified peptides from established suppliers maintain consistent activity across multiple productions.
Typical stock concentrations range from 1–10 mg/mL depending on dose volumes and injection routes planned for your protocol. For subcutaneous dosing in rodent behavioral studies, 2–5 mg/mL stock solutions in bacteriostatic water allow convenient injection volumes of 0.05–0.2 mL to deliver doses in the 0.5–3 mg/kg range commonly reported in the literature. Higher concentrations (>10 mg/mL) risk incomplete dissolution or precipitation during refrigerated storage. Always prepare fresh dilutions in saline or appropriate vehicle for each dosing session rather than repeatedly withdrawing from the same stock vial to minimize contamination and freeze-thaw degradation.
Lyophilized peptides can tolerate brief ambient temperature exposure during shipping (24–48 hours at 20–25°C), but temperatures above 30°C accelerate degradation exponentially — each 10°C increase approximately doubles the degradation rate. Summer shipping in non-insulated packaging routinely exposes peptides to 35–45°C inside delivery vehicles, causing tryptophan oxidation and structural changes visible on HPLC as shifted retention times or new impurity peaks. Temperature-monitored cold chain shipping with data loggers provides documentation of the thermal history, allowing you to reject shipments that experienced excursions and ensuring the peptide you receive matches the stability data from controlled storage conditions.
HPLC measures purity by comparing peak areas but cannot distinguish between the correct sequence and a closely-related impurity with similar retention time — a deletion sequence missing one amino acid might elute within 0.3 minutes of the target peak and appear as a single ‘pure’ peak on lower-resolution systems. Mass spectrometry confirms the actual molecular weight (1025.2 g/mol for bremelanotide), revealing whether impurity peaks represent deletion sequences (lower mass), addition sequences (higher mass), or oxidized variants (16 Da higher per oxygen). For dose-response studies where receptor affinity is the experimental variable, knowing your peptide contains 95% target sequence and 5% deletion sequence versus 99% target sequence changes interpretation of every data point.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now